Indocyanine green angiography and retinal sensitivity after photodynamic therapy of subfoveal choroidal neovascularization

Seminars in Ophthalmology

Volumn 14, Issue 1, 1999, Pages 35-44

  Schmidt Erfurth, Ursula ^a,b  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^b UNIVERSITY OF LÜBECK   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

INDOCYANINE GREEN; VASCULOTROPIN;

ANIMAL MODEL; ARTICLE; CHOROID DISEASE; CLINICAL TRIAL; DOUBLE BLIND PROCEDURE; FLUORESCENCE ANGIOGRAPHY; HUMAN; MULTICENTER STUDY; NONHUMAN; PERIMETRY; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; RECURRENT DISEASE; SUBRETINAL NEOVASCULARIZATION; VISUAL ACUITY;

EID: 0032962513     PISSN: 08820538     EISSN: None     Source Type: Journal    
DOI: 10.3109/08820539909056061     Document Type: Article

References (33)

1. Ramrattan Raan S, van der Schaft TL, Mooy CM, et al. Morphometic analysis of Bruch's membrane, the choriocapillaris, and the choroid in aging. IOVS. 1994;35:2857-2864.
2. Van der Schaft TL, Mooy CM, de Bruijn WC, et al. Histological features of the early stages of age-related macular degeneration. Ophthalmology. 1992;99:278-286.
3. Spraul CW, Lang GE, Grossniklaus HE. Morphometric analysis of the choroid, Bruch's membrane, and retinal pigment epithelium in eyes with age-related macular degeneration. IOVS. 1996;37:2724-2735.
4. Bressler SB, Bressler NM, Fine SL. Natural course of choroidal neovascular membranes within the foveal avaseular zone in senile macular degeneration. Am J Ophthalmol. 1982;93:157-163.
5. Green WR, McDonnell PJ, Yeo JH. Pathologic features of senile macular degeneration. Ophthalmology. 1985;92:615-627.
6. Green WR, Enger C. Age-related macular degeneration: Histopathological studies. Ophthalmology. 1993;100:1519-1535.
7. Marshall J, Bird AC. A comparative histopathological study of argon and krypton laser irradiations on the human retina. Br J Ophthalmol. 1979;63:657-668.
8. Macular Photocoagulation Study Group. Laser photocoagulation of subfoveal neovascular lesions. Arch Ophthalmol. 1993;111:1200-1209.
9. Bressler SB. Does wavelength matter when photocoagulating eyes with macular degeneration or diabetic retinopathy? Arch Ophthalmol. 1993;111:177-180.
10. Coscas G, Soubrane G, Ramahefasolo C, et al. Perifoveal laser treatment for subfoveal choroidal new vessels in age-related macular degeneration. Arch Ophthalmol. 1991;109: 1258-1265.
11. Bressler NM, Maguire MS, Murphy PL, et al. Macular scatter (grid) laser treatment of poorly demarcated subfoveal choroidal neovascularization in age related-macular degeneration. Arch Ophthalmol. 1996;114:1456-1464.
12. Shiraga F, Ojima Y, Matsuo M, et al. Feeder vessel photocoagulation of subfoveal choroidal neovascularization secondary to age-related macular degeneration. Ophthalmology. 1998; 105:662-669.
13. Milanesi C, Biolo R, Reddi E, et al. Ultrastructural studies on the mechanisms of photodynamic therapy of tumors. Photochem. Photobiol. 1987;46:675-681.
14. Henderson BW, Dougherty TJ. How does PDT work? Photochem Photobiol. 1992;55:145-157.
15. Moan JK, Berg K. The photodegradation of porphyrin in cells can be used to estimate the lifetime of singlet oxygen. Photochem Photobiol. 1991;53:549-553.
16. Gomer CJ, Rucker N, Murphree AL. Differential cell photosensitivity following porphyrin photodynamic therapy. Cancer Res. 1988;48:4539-4542.
17. Vlodansky I, Fielding PE, Fielding CJ, et al. Role of contact inhibition in the regulation of receptor-mediated uptake of low-density lipoprotein in cultures of vascular endothelial cells. Proc Natl Acad Sci USA 1978;75:356-360.
18. Roberts WG, Hasan T. Role of neovasculature and vascular permeability on the tumor retention of photodynamic agents. Cancer Res. 1992;52:924-930.
19. Schmidt-Erfurth U, Hasan T, Gragoudas E, et al. Vascular targeting in photodynamic occlusion of subretinal vessels. Ophthalmology. 1994;101:1953-1961.
20. Miller JW, Walsh A, Kramer M, et al. Photodynamic therapy of experimental choroidal neovascularization. Arch Ophthalmol. 1995;113:810-818.
21. Husain D, Miller JW, Michaud N, et al. Intravenous infusion of liposomal BPD for photodynamic therapy of experimental choroidal neovascularization. Arch Ophthalmol. 1996; 114:978-985.
22. Schmidt-Erfurth U, Miller J, Sickenberg M, et al. Photodynamic therapy of subfoveal choroidal neovascularization. Clinical and angiographic examples. Graefe's Arch Clin Exp Ophthalmol. 1998;236:365-374.
23. Fingar VH, Wieman TJ, Doak KW. Role of thromboxane and prostacyclius release on photodynamic therapy - induced tumor destruction. Cancer Res. 1990;50:2599-2603.
24. Caskey PJ, Falk JC. Retinal revascularization following laser photocoagulation treatment for choroidal neovascular membranes. Arch Ophthalmol. 1988;106:1528-1532.
25. Lutty GA, Mc Leod S, Merges C, et al. Localization of vascular endothelial growth factor in human retina and choroid. Arch Ophthalmol. 1996;114:971-977.
26. Kvanta A, Algvere PV, Berglin L, et al. Subfoveal fibrovascular membranes in age-related macular degeneration express vascular endothelial growth factor. IOVS. 1996; 37:1929-1934.
27. Pluming LC, Keirse MJ, Van Steveninck J, et al. Ca (2+)-mediated prostaglandin E2 induction reduces haematoporphyrin-derivative-induced cytotoxicity of T24 human bladder transitional carcinoma cells in vitro. Biochem J. 1993;292:237-240.
28. Fingar VH, Wilman TJ, Wiehle SA, et al. The role of microvascular damage in photodynamic therapy: The effect of treatment on vessel constriction, permeability, and leukocyte adhesion. Cancer Res. 1992;52:4914-4921.
29. Dastgheib K, Green R. Granulomatous reaction to Bruch's membrane in age-related macular degeneration. Arch Ophthalmol. 1994;112:813-818.
30. Penfold PL, Liew SCK, Madigan MC, et al. Modulation of major histocompatibility complex class II expression in retinas with age-related macular degeneration. IOVS. 1992;38: 2125-2134.
31. D'Amato R, Adamis A. Angiogenesis inhibition in age-related macular degeneration. Ophthalmology. 1995;102: 1261-1262.
32. Lopez PT, Sippy BP, Lambert HM, et al. Transdifferentiated retinal pigment epithelial cells are immunoreactive for vascular endothelial growth factor in surgically excised choroidal neovascular membranes in age-related macular degeneration. IOVS. 1996;37:855-868.
33. Miller H, Miller B, Ryan SJ. The role of retinal pigment epithelium in the involution of subretinal neovascularization. IOVS. 1986;27:1644-1652.